Ranibizumab and endophthalmitis Patient Reports February 11, 2012
Ranibizumab Side Effects Report #5727551-1
Ranibizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Apr 21, 2008. Male patient, weighting 121.3 lb, was diagnosed with choroidal neovascularisation and was treated with Ranibizumab. After drug was administered, patient experienced the following side effects: endophthalmitis. Ranibizumab dosage: 0.5 MG, 1/MONTH. Patient was hospitalized. Patient recovered.
Ranibizumab Side Effects Report #5738364-9
Ranibizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on May 05, 2008. Male patient, weighting 121.3 lb, was diagnosed with choroidal neovascularisation and was treated with Ranibizumab. After drug was administered, patient experienced the following side effects: endophthalmitis. Ranibizumab dosage: 0.5 MG, 1/MONTH. Patient was hospitalized. Patient recovered.
Ranibizumab Side Effects Report #5758923-7
Ranibizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on May 27, 2008. Male patient, weighting 121.3 lb, was diagnosed with choroidal neovascularisation and was treated with Ranibizumab. After drug was administered, patient experienced the following side effects: endophthalmitis. Ranibizumab dosage: 0.5 MG, 1/MONTH. Patient was hospitalized. Patient recovered.
Ranibizumab Side Effects Report #6008466-0
Ranibizumab side effect was reported by a Physician from SWITZERLAND on Dec 02, 2008. Female patient was treated with Ranibizumab. After drug was administered, patient experienced the following side effects: endophthalmitis, visual acuity reduced. Ranibizumab dosage: 0.5 MG, UNK. During the same period patient was treated with LOMEFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Ranibizumab Side Effects Report #6023918-5
Ranibizumab side effect was reported by a Physician from SWITZERLAND on Dec 18, 2008. Female patient was treated with Ranibizumab. After drug was administered, patient experienced the following side effects: endophthalmitis, visual acuity reduced. Ranibizumab dosage: 0.5 MG, UNK. During the same period patient was treated with LOMEFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Ranibizumab Side Effects Report #6035102-X
Ranibizumab side effect was reported by a Physician from SWITZERLAND on Dec 31, 2008. Female patient was treated with Ranibizumab. After drug was administered, patient experienced the following side effects: endophthalmitis, visual acuity reduced. Ranibizumab dosage: 0.5 MG, UNK. During the same period patient was treated with LOMEFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Ranibizumab and endophthalmitis 